1. The interplay between alterations in esophageal microbiota associated with Th17 immune response and impaired LC20 phosphorylation in achalasia

   • Hiroko Ikeda
   • Eikichi Ihara
   • Yoshihiro Ogawa

   Original Article—Alimentary Tract 12 March 2024 Pages: 361 - 375

   

2. Clinicopathological features and prognosis of primary small bowel adenocarcinoma: a large multicenter analysis of the JSCCR database in Japan

   • Ken Yamashita
   • Shiro Oka
   • Shinji Tanaka

   Original Article—Alimentary Tract Open access 27 February 2024 Pages: 376 - 388

   

3. Change in systemic steroid use and surgery rate in patients with inflammatory bowel disease: a Japanese real-world database analysis

   • Daisuke Hirayama
   • Shinichiro Hyodo
   • Hiroshi Nakase

   Original Article—Alimentary Tract Open access 16 March 2024 Pages: 389 - 401

   

4. Efficacy, tolerability, and safety of oral sulfate tablet versus 2 L-polyethylene glycol/ascorbate for bowel preparation in older patients: prospective, multicenter, investigator single-blinded, randomized study

   • Ho Suk Kang
   • Soo-Young Na
   • Jae Myung Cha

   Original Article—Alimentary Tract 16 March 2024 Pages: 402 - 410

   

5. Characterization of tumor microbiome and associations with prognosis in intrahepatic cholangiocarcinoma

   • Hao-Yang Xin
   • Ji-Xue Zou
   • Shao-Lai Zhou

   Original Article―Liver, Pancreas, and Biliary Tract 10 March 2024 Pages: 411 - 423

   

6. Pancreatic injury in patients treated with immune checkpoint inhibitors: a retrospective multicenterstudy

   • Kae Nagao
   • Arata Sakai
   • Yuzo Kodama

   Original Article―Liver, Pancreas, and Biliary Tract Open access 29 February 2024 Pages: 424 - 433

   

7. A revolutionary oral HBV treatment candidate as innovative therapeutic approach warranting clinical trials

   • Takeshi Matsui

   Editorial 25 March 2024 Pages: 434 - 435